Over the past two decades, researchers have learned that DNA inside the cell nucleus naturally folds into a network of ...

Chromosome shenanigans have resulted in some unexpected hybrid fishes. Also, this record-breaking mouse lives at a ridiculous ...

Designed to reinforce lucerastat as the first oral therapy suitable for all patients with Fabry disease, irrespective of their mutation type. The program is expected to support a potential regulatory ...

Allschwil, Switzerland - February 06, 2026Idorsia Ltd (SIX: IDIA) announces the design of its FDA-agreed Phase 3 registration program for lucerastat in Fabry disease. Building on the robust biomarker ...